The 22 analysts offering 12-month price forecasts for CVS Health Corp have a median target of 89.50, with a high estimate of 110.00 and a low estimate of 76.00. The median estimate represents a +29.22% increase from the last price of 69.26.
The current consensus among 26 polled investment analysts is to Buy stock in CVS Health Corp. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $2.17
Reporting Date Nov 01
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.